Page 1 | Search Results | Blood Advances | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Blood Adv (2024) 8 (11): 2890–2900.

https://doi.org/10.1182/bloodadvances.2024012756

Published: 2024

Includes: Supplemental data

Journal Articles

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Vanessa E. Kennedy, Cecelia Perkins, Andreas Reiter, Mohamad Jawhar, Johannes Lübke, Hanneke C. Kluin-Nelemans, William Shomali, Cheryl Langford, Justin Abuel, Olivier Hermine, Marek Niedoszytko, Aleksandra Gorska, Andrzej Mital, Patrizia Bonadonna, Roberta Zanotti, Ilaria Tanasi, Mattias Mattsson, Hans Hagglund, Massimo Triggiani, Akif Selim Yavuz, Jens Panse, Deborah Christen, Marc Heizmann, Khalid Shoumariyeh, Sabine Müller, Chiara Elena, Luca Malcovati, Nicolas Fiorelli, Friederike Wortmann, Vladan Vucinic, Knut Brockow, Christos Fokoloros, Sotirios G. Papageorgiou, Christine Breynaert, Dominique Bullens, Michael Doubek, Anja Ilerhaus, Irena Angelova-Fischer, Oleksii Solomianyi, Judit Várkonyi, Vito Sabato, Axel Rüfer, Tanja Daniela Schug, Maud A. W. Hermans, Anna Belloni Fortina, Francesca Caroppo, Horia Bumbea, Theo Gulen, Karin Hartmann, Hanneke Oude Elberink, Juliana Schwaab, Michel Arock, Peter Valent, Wolfgang R. Sperr, Jason Gotlib

Blood Adv (2023) 7 (9): 1713–1724.

https://doi.org/10.1182/bloodadvances.2022008292

Published: 2023

Includes: Supplemental data

Journal Articles

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Blood Adv (2021) 5 (10): 2481–2489.

https://doi.org/10.1182/bloodadvances.2020003605

Published: 2021

Includes: Supplemental data

Journal Articles

Delineation of target expression profiles in CD34 + /CD38 − and CD34 + /CD38 + stem and progenitor cells in AML and CML

Harald Herrmann, Irina Sadovnik, Gregor Eisenwort, Thomas Rülicke, Katharina Blatt, Susanne Herndlhofer, Michael Willmann, Gabriele Stefanzl, Sigrid Baumgartner, Georg Greiner, Axel Schulenburg, Niklas Mueller, Werner Rabitsch, Martin Bilban, Gregor Hoermann, Berthold Streubel, Daniel A. Vallera, Wolfgang R. Sperr, Peter Valent

Blood Adv (2020) 4 (20): 5118–5132.

https://doi.org/10.1182/bloodadvances.2020001742

Published: 2020

Includes: Supplemental data

Journal Articles

Variability of PD-L1 expression in mastocytosis

Ellen W. Hatch, Mary Beth Geeze, Cheyenne Martin, Mohamed E. Salama, Karin Hartmann, Gregor Eisenwort, Katharina Blatt, Peter Valent, Jason Gotlib, Ji-Hyun Lee, Lu Chen, Heather H. Ward, Diane S. Lidke, Tracy I. George

Blood Adv (2018) 2 (3): 189–199.

https://doi.org/10.1182/bloodadvances.2017011551

Published: 2018

Includes: Supplemental data

NARROW

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Delineation of target expression profiles in CD34 + /CD38 − and CD34 + /CD38 + stem and progenitor cells in AML and CML

Variability of PD-L1 expression in mastocytosis

Email alerts

ASH Publications

American Society of Hematology

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Delineation of target expression profiles in CD34 + /CD38 − and CD34 + /CD38 + stem and progenitor cells in AML and CML

Variability of PD-L1 expression in mastocytosis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only